COMP <GO>
ARDX vs JNJ // NET PROFIT MARGIN
Ardelyx Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: ARDX 2
— JNJ 8
▲ NET PROFIT MARGIN LEADER: JNJ
LAST: $3.10 (0.00%) • MKT CAP: $772.5M
net-margins
-15.20%
LAST: $275.20 (+1.54%) • MKT CAP: $662.49B
net-margins
28.50%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ARDX VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ARDX | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 90.30% | 67.90% | +22.40 | ARDX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -32.70% | 25.50% | -58.20 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 18.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -5.69% | 2.97% | -8.66 | JNJ | /fcf-yield <GO> |
| Operating Margin | -10.10% | 34.70% | -44.80 | JNJ | /operating-margins <GO> |
| Net Profit Margin ACTIVE | -15.20% | 28.50% | -43.70 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 22.10% | 6.00% | +16.10 | ARDX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 5.59 | -5.39 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 8/9 | -4.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 37.3 | 62.1 | -24.81 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 23.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $772.5M | $662.49B | -$661.72B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ARDX REV | JNJ REV | ARDX GROSS % | JNJ GROSS % | ARDX FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $407.3M | $94.19B | 90.3% | 67.9% | -$44.0M | $19.70B |
| FY 2024 | $333.6M | $88.82B | 84.8% | 69.1% | -$45.8M | $19.84B |
| FY 2023 | $124.5M | $85.16B | — | — | -$89.7M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ARDX // BETA —
JNJ // BETA 1.08